Failure Patterns after Definitive Chemoradiation Therapy with Involved-Field Irradiation for Locally Advanced Esophageal Squamous Cell Carcinoma

M. Li,X. Zhang,Zhongxing Liao,Xue Meng,Li Kong,Xiang Zhang,Fang Shi,Yong Zhang,Wei Guo,Honghao Man,G Y Zhang,Jinming Yu

DOI: https://doi.org/10.1016/j.ijrobp.2014.05.092

2014-01-01

Abstract:Because locally advanced esophageal squamous cell carcinoma (ESCC) is associated with high local failure rates and poor survival, the need for potentially toxic elective nodal irradiation is controversial. The purpose of this study was to investigate failure patterns and survival in patients with locally advanced ESCC after receipt of definitive concurrent chemoradiation with involved-field irradiation (IFI). A retrospective study was performed on the clinical records of patients with locally advanced ESCC, who have received IFI with concurrent chemotherapy between January 2003 and January 2009. The target volume included the esophageal lesion and clinically malignant nodes. No prophylactic nodal irradiation was used. We compared target volumes and first sites of failure; failures were defined as in-field, out-of-field regional nodes, and distant failure. Survival was analyzed according to patterns of failure. Complete data were available for 80 patients. At a median follow-up time of 52.6 months, 76 patients (95%) had experienced failure (43 [54%] in-field, 24 [30%] out-of-field regional, and 33 [41%] distant). Overall survival differed significantly by in-field recurrence (median 14.2 months with vs.17.4 months without, P = 0.01) and by distant failure (13.2 months with vs.15.9 months without, P ≤ 0.0001), but not by out-of-field regional lymph node failure (both 14.5 months, P = 0.665). The failure rate of in-field alone, distant alone, and out-of-field regional LN alone were 40%, 16.25%, and 12.5%, respectively. All of the 10 cases with solitary regional LN failure received salvage treatment and 4 of them experienced more than 24 months survival period. The predominant failure patterns after definitive chemoradiation with IFI for locally advanced ESCC were in-field and distant, and both negatively influenced survival. Having a solitary failure in an out-of-field regional node did not influence survival. Further investigation is needed to establish the optimal radiotherapy fields for patients with advanced disease.